Ascertainment of cause-specific mortality in COPD: operations of the TORCH Clinical Endpoint Committee - Wikidata - awgldk - TriplyDB

Ascertainment of cause-specific mortality in COPD: operations of the TORCH Clinical Endpoint Committee

Ascertainment of cause-specific mortality in COPD: operations of the TORCH Clinical Endpoint Committee

http://www.wikidata.org/entity/Q36740784

about

"Sentinel" circulating tumor cells allow early diagnosis of lung cancer in patients with chronic obstructive pulmonary disease Comparison of central adjudication of outcomes and onsite outcome assessment on treatment effect estimates Long-acting beta2-agonists for chronic obstructive pulmonary disease Long-acting inhaled therapy (beta-agonists, anticholinergics and steroids) for COPD: a network meta-analysis Inhaled steroids and risk of pneumonia for chronic obstructive pulmonary disease Combined corticosteroid and long-acting beta(2)-agonist in one inhaler versus inhaled corticosteroids alone for chronic obstructive pulmonary disease Combined corticosteroid and long-acting beta(2)-agonist in one inhaler versus long-acting beta(2)-agonists for chronic obstructive pulmonary disease Combined corticosteroid and long-acting beta 2 -agonist in one inhaler versus placebo for chronic obstructive pulmonary disease Inhaled corticosteroids versus long-acting beta2-agonists for chronic obstructive pulmonary disease Inhaled corticosteroids versus long-acting beta 2 -agonists for chronic obstructive pulmonary disease Combined corticosteroid and long-acting beta-agonist in one inhaler versus inhaled steroids for chronic obstructive pulmonary disease Combined corticosteroid and long-acting beta-agonist in one inhaler versus placebo for chronic obstructive pulmonary disease Combined corticosteroid and long-acting beta-agonist in one inhaler versus long-acting beta-agonists for chronic obstructive pulmonary disease Clinical, humanistic, and economic burden of chronic obstructive pulmonary disease (COPD) in Canada: a systematic review Comorbidities and Chronic Obstructive Pulmonary Disease: Prevalence, Influence on Outcomes, and Management Managing comorbidities in COPD Validity of COPD diagnoses reported through nationwide health insurance systems in the People's Republic of China Temporal trends in hospitalization rates for older adults with chronic obstructive pulmonary disease Lower extremity and carotid artery disease in COPD Lung cancer and chronic obstructive pulmonary disease: needs and opportunities for integrated research New clinical insights into chronic obstructive pulmonary disease and their implications for pharmacoeconomic analyses Comparative ability of comorbidity classification methods for administrative data to predict outcomes in patients with chronic obstructive pulmonary disease.Determinants of cardiac troponin T elevation in COPD exacerbation - a cross-sectional study SUV39H1 Reduction Is Implicated in Abnormal Inflammation in COPD.COPD is a clear risk factor for increased use of resources and adverse outcomes in patients undergoing intervention for colorectal cancer: a nationwide study in Spain.ANMCO/GICR-IACPR/SICI-GISE Consensus Document: the clinical management of chronic ischaemic cardiomyopathy Associations of chronic obstructive pulmonary disease with all-cause mortality in Blacks and Whites: the atherosclerosis risk in communities (ARIC) study.Obesity, adipokines, and lung disease Systemic inflammation in chronic obstructive pulmonary disease: may adipose tissue play a role? Review of the literature and future perspectives.Does pulmonary rehabilitation address cardiovascular risk factors in patients with COPD?Design and execution of clinical trials in orthopaedic surgery.Elevated N-terminal pro-brain natriuretic peptide is associated with mortality in tobacco smokers independent of airflow obstruction.Epidemiology and clinical impact of major comorbidities in patients with COPD.Why does lung function predict mortality? Results from the Whitehall II Cohort Study.Cardiovascular and musculskeletal co-morbidities in patients with alpha 1 antitrypsin deficiency.Severe chronic pain is associated with increased 10 year mortality. A cohort record linkage study.Agreement on cause of death between proxies, death certificates, and clinician adjudicators in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) study Cardiovascular and inflammatory effects of simvastatin therapy in patients with COPD: a randomized controlled trial High prevalence of altered cardiac repolarization in patients with COPD.Excessive visceral fat accumulation in advanced chronic obstructive pulmonary disease.

P2860

Q21131903-E6C9184F-A050-4129-9A2C-60E454DE63ED Q24186056-C1661BB4-DB31-4A5F-B3A4-DB4B4B9F604A Q24197467-CB7F783C-8C16-40D1-8EFA-0E3874C1FE33 Q24197853-99C2AD3C-5CDF-42ED-BA4C-A875C82F013D Q24197989-623E7489-03C2-4AEE-89F7-D7092F34F53E Q24199130-6B877329-2FA6-4E5D-8D5C-26AF824466E4 Q24200446-2C54E5B1-0E98-4863-8F10-882D2657BA43 Q24202510-8B472B36-8213-4D06-A0FB-C48181F8617D Q24234164-E7A98CF7-31D1-4ABF-B6AF-018FD818420B Q24236037-0F0131D9-8B8A-46A7-AC39-95EBFCE7C129 Q24243515-99AD7FA4-710B-4E0A-B869-5F1E2BC14430 Q24243564-1468803E-36E1-4CC5-B751-3E94DEF855F2 Q24243613-0198BF1B-2281-4BBB-AE46-54FBD12D3603 Q26782630-9A728215-6831-49AF-92B5-365714D85760 Q26799659-E15ADCA8-B2B3-48B0-9F47-7A7CC121C669 Q27005858-BA48C799-7A69-4211-A4C4-EE4C879C9D4D Q28388949-B6F13157-6BEF-4ABD-A245-9F08A27D8A14 Q28391590-620A9F5F-9631-442A-9500-2A2CD3DB5EA6 Q28587857-D0C45C2B-6060-409A-B92F-EBF8BC62062F Q28754732-B7EDEA14-D542-45FD-99E6-45DA4BC90843 Q30419928-65BA225A-5971-4D52-901A-E37499B0B3DB Q30575851-2C9B035B-8AA1-444E-8DC0-39331CF223BA Q33483732-41AA855A-C091-4EE0-B822-D3D6B083DA0F Q33582967-8F921BED-25DA-4FDD-93DF-772B008D1B9A Q33609998-601488AA-FDDF-4C8B-8D01-F39D12098958 Q33647497-46CA4B99-EE29-4E11-9890-C72C87A960C6 Q33677355-660F69A4-DD54-4662-B986-26199026830B Q33728020-E03E6658-1CF7-4DEA-949B-6D18AF437B86 Q33802207-08C25718-DEBF-4835-B51B-9AACCEAFFBC0 Q33878940-E59CB23A-8D43-4E96-AE53-D6E6B8DB6318 Q33900666-F49D1221-FC24-4E95-8FEA-8264CF21622A Q34075676-8FDC640F-19C7-491C-A51E-DC81ACCB0C49 Q34134841-D8A45EF1-6012-4A90-8920-DF0A82C42700 Q34386333-799B245D-EFB5-42E3-82B2-40FBD12D85EC Q34419196-C865AB79-8AC5-40F9-8AF0-41C95F191503 Q35000895-D85C07F0-341B-4550-9627-86DEDB4221F7 Q35003451-8053DD0D-BECA-449B-85D2-A7ADACCBAD19 Q35063739-966D0DB1-3374-4415-928B-72A4D6E46732 Q35136929-69B776E5-4FE9-41D3-B2DE-AA52E75858AF Q35170150-552D3BB0-4300-4CCC-A914-40F5EDBF60AC

P2860

Ascertainment of cause-specific mortality in COPD: operations of the TORCH Clinical Endpoint Committee

http://www.wikidata.org/entity/Q36740784

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Ascertainment of cause-specifi ...... CH Clinical Endpoint Committee

@ast

Ascertainment of cause-specifi ...... CH Clinical Endpoint Committee

@en

type

label

Ascertainment of cause-specifi ...... CH Clinical Endpoint Committee

@ast

Ascertainment of cause-specifi ...... CH Clinical Endpoint Committee

@en

prefLabel

Ascertainment of cause-specifi ...... CH Clinical Endpoint Committee

@ast

Ascertainment of cause-specifi ...... CH Clinical Endpoint Committee

@en

P1433

Q36740784-0D96C596-BE74-46BE-A64D-667A6492B322

P1476

Q36740784-76A28CD4-33E1-412E-8359-A473499E7B84

P2093

Q36740784-32AD147C-2A42-480A-A545-0AAA15A8BA05

Q36740784-6FC66286-B19F-45EA-8A92-BC112D8B0520

Q36740784-8483E382-DADF-4828-A5AE-F78B270D44C2

Q36740784-D0962BDE-6094-429A-A67B-81A1ED24B9E2

Q36740784-E801AD6D-FD0E-403B-ABA5-3BD6D86DDA80

P2860

Q36740784-024B7943-91DA-4DEE-8737-B351CD1A007E

Q36740784-1B8F0A36-97CB-4A64-8E9E-DB01F651AE04

Q36740784-2C3CFB40-4C90-4597-8525-BD4DA698B10B

Q36740784-3E9BAF05-FBF0-4B87-AEFD-3D9AD246784D

Q36740784-3F8E6E8B-42F7-4604-B748-F2E766C0BFCA

Q36740784-56DA4E3B-5364-475D-AE5B-41633856E179

Q36740784-60DD7AE1-CE88-4778-A1A7-F7DB2ABDE573

Q36740784-6A708602-6EFD-4595-A160-2E0CA2E258D5

Q36740784-7773057D-6935-4831-81CA-0E9B7EEBDD8B

Q36740784-7D430AF5-71EE-4DC3-8AEC-D9B84173CEB2

P304

Q36740784-1310B0DE-4FD4-4B81-87F1-ADA67B1DA5A6

P31

Q36740784-D81285E9-990F-4819-AB8A-D80A821169A6

P356

Q36740784-5496320D-D11B-448B-8C63-EEB689376E60

P407

Q36740784-86AE8162-DC72-4D50-B4E0-69B492A8EDAA

P433

Q36740784-70C4F3FB-93C5-4766-9C74-415995A3C732

P478

Q36740784-5DE4F3B1-23E1-48DE-9B65-E166C8803DA0

P50

Q36740784-AD6BEC5A-B588-4E86-82AD-A7B49B7907E3

P577

Q36740784-D2D2090E-1672-4540-9009-E5B8095F057F

P5875

Q36740784-64A423E4-240F-4E78-B6BF-F499B5F8ECD0

P698

Q36740784-12D647E8-AF89-46BD-B09E-9FBCD8A001DE

P932

Q36740784-CE66419E-35BF-45C6-B391-5E430019FA4A

P356

THX.2006.072348

P1433

P1476

Ascertainment of cause-specifi ...... CH Clinical Endpoint Committee

@en

P2093

Julie A Anderson

http://www.w3.org/2001/XMLSchema#string

Lorcan P McGarvey

http://www.w3.org/2001/XMLSchema#string

Matthias John

http://www.w3.org/2001/XMLSchema#string

Michael Zvarich

http://www.w3.org/2001/XMLSchema#string

TORCH Clinical Endpoint Committee

http://www.w3.org/2001/XMLSchema#string

P2860

Systematic adjudication of myocardial infarction end-points in an international clinical trial

Disagreements between central clinical events committee and site investigator assessments of myocardial infarction endpoints in an international clinical trial: review of the PURSUIT study

Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study

Cause of death in clinical research: time for a reassessment?

Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study.

The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial.

Misreporting of myocardial infarction end points: results of adjudication by a central clinical events committee in the PARAGON-B trial. Second Platelet IIb/IIIa Antagonist for the Reduction of Acute Coronary Syndrome Events in a Global Organization

Comparison of self-report, hospital discharge codes, and adjudication of cardiovascular events in the Women's Health Initiative.

Reliability of death certificate diagnoses.

Spirometric findings and mortality in never-smokers.

P304

411-415

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/THX.2006.072348

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

62

http://www.w3.org/2001/XMLSchema#string

P50

P577

2007-02-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6493582

http://www.w3.org/2001/XMLSchema#string

P698

17311843

http://www.w3.org/2001/XMLSchema#string

P932

2117197

http://www.w3.org/2001/XMLSchema#string